CORDIS · 229612 · FP7
AFR-PD AFR - Postdoctoral Grants (Luxembourg)
Coordinator: FONDS NATIONAL DE LA RECHERCHE (LU)
On 1st October 2008, the law reforming the former national PhD and postdoctoral grant scheme BFR (Bourses Formation-Recherche) under the new title of Aides à la Formation-Recherche (AFR) entered into force. While the BFR scheme has so far been managed by the Ministry of Research, the future AFR grant scheme will be managed by the National Research Fund (FNR).The AFR grant scheme comprises two activities: the funding of PhD grants (AFR-PhD) and the funding of postdoctoral grants (AFR-PD). In this document, when using AFR, both schemes are meant; otherwise the text will refer to AFR-PD.The main…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
Co-funding: the European Union contributes €3.2M toward a total project budget of €7.9M — a funding rate of 40%, with the remainder covered by the consortium partners. The project runs over approximately 4 years from 2009-03-02 to 2013-03-01.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from LU
see all →- HEDGE-IoT — Holistic Approach towards Empowerment of the DiGitalization of the Energy Ecosystem through adoption of IoT solutions101136216 · HORIZON · €18.0M
- DESIDERATA — Integrated Pathways: Advancing Safe and Sustainable by Design Material Innovation through Collaborative Wisdom101178011 · HORIZON · €10.7M
- TrustChain — Fostering a Human-Centered, Trustworthy and Sustainable Internet101093274 · HORIZON · €10.6M
- HealthyW8 — Empowering healthy lifestyle behaviour through personalised intervention portfolios to prevent and control obesity during vulnerable stages of life101080645 · HORIZON · €10.0M
- PATH — Patient AI Treatment Hub101253520 · HORIZON · €8.9M
- ALCEMIST — Atypical Liquid Crystal Elastomers: from Materials Innovation to Scalable processing and Transformative applications101167171 · HORIZON · €8.5M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the MC-COFUND funding scheme.
- What is the EU contribution?
- The European Commission contributes €3.2M toward a total project budget of €7.9M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by FONDS NATIONAL DE LA RECHERCHE (LU).
- What is the project timeline?
- The project runs from 2009-03-02 to 2013-03-01 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 229612.